Concepedia

Alessandro Bonifazi

AB

58

Publications

1.8K

Citations

25

H-Index

2012

Active since

Affiliations

National Institute on Drug Abuse(Current)

National Institutes of Health

Università di Camerino

University of Milan

Johns Hopkins University

Alessandro Bonifazi is an author at National Institute on Drug Abuse specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2012–2025

58

Publications

58

Highly Selective Dopamine D<sub>3</sub> Receptor (D<sub>3</sub>R) Antagonists and Partial Agonists Based on Eticlopride and the D<sub>3</sub>R Crystal Structure: New Leads for Opioid Dependence Treatment

Vivek Kumar, Alessandro Bonifazi, Michael P. Ellenberger et al. · Journal of Medicinal Chemistry · 2016 · 87 citations · Full text

, , +21

Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist

Marta Sánchez‐Soto, Alessandro Bonifazi, Ning Cai et al. · Molecular Pharmacology · 2016 · 83 citations · Full text

The highly selective dopamine D R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents

Chloe J. Jordan, Bree A. Humburg, M. S. RICE et al. · Neuropharmacology · 2019 · 70 citations · Full text

, , +10

2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts

Amy Hauck Newman, Francisco O. Battiti, Alessandro Bonifazi · Journal of Medicinal Chemistry · 2019 · 69 citations · Full text

, , +19

Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors

Jianjing Cao, Rachel D. Slack, Oluyomi M. Bakare et al. · Journal of Medicinal Chemistry · 2016 · 65 citations · Full text

Rows per page

1–5 of 58